Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (SHA:603811)
China · Delayed Price · Currency is CNY 11.53
+0.03 (0.26%)
Feb 4, 2026, 3:00 PM CST
SHA:603811 Revenue
Zhejiang Cheng Yi Pharmaceutical had revenue of 180.36M CNY in the quarter ending September 30, 2025, with 9.47% growth. This brings the company's revenue in the last twelve months to 790.86M, up 7.94% year-over-year. In the year 2024, Zhejiang Cheng Yi Pharmaceutical had annual revenue of 714.37M with 6.36% growth.
Revenue (ttm)
790.86M
Revenue Growth
+7.94%
P/S Ratio
4.62
Revenue / Employee
1.24M
Employees
637
Market Cap
3.65B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 714.37M | 42.74M | 6.36% |
| Dec 31, 2023 | 671.63M | 16.65M | 2.54% |
| Dec 31, 2022 | 654.97M | -38.99M | -5.62% |
| Dec 31, 2021 | 693.96M | -64.17M | -8.46% |
| Dec 31, 2020 | 758.13M | 76.90M | 11.29% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition